Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors

被引：34

作者：

Fucini, Raymond V. ^{[1
]}

Hanan, Emily J. ^{[2
]}

Romanowski, Michael J. ^{[3
]}

Elling, Robert A. ^{[3
]}

Lew, Willard ^{[2
]}

Barr, Kenneth J. ^{[2
]}

Zhu, Jiang ^{[2
]}

Yoburn, Joshua C. ^{[2
]}

Liu, Yang ^{[2
]}

Fahr, Bruce T. ^{[2
]}

Fan, Junfa ^{[2
]}

Lu, Yafan ^{[2
]}

Pham, Phuongly ^{[2
]}

Choong, Ingrid C. ^{[2
]}

VanderPorten, Erica C. ^{[1
]}

Bui, Minna ^{[2
]}

Purkey, Hans E. ^{[2
]}

Evanchik, Marc J. ^{[1
]}

Yang, Wenjin ^{[2
]}

机构：

[1] Sunesis Pharmaceut Inc, Dept Biol, San Francisco, CA 94080 USA

[2] Sunesis Pharmaceut Inc, Dept Chem, San Francisco, CA 94080 USA

[3] Sunesis Pharmaceut Inc, Dept Biol Struct, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 20期

关键词：

2-amino-pyrazolopyridine; Polo-like kinase (Plk); SAR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2008.08.095

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 2-amino-pyrazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors based on a low micromolar hit. The SAR was developed to provide compounds exhibiting low nanomolar inhibitory activity of Plk1; the phenotype of treated cells is consistent with Plk1 inhibition. A co-crystal structure of one of these compounds with zPlk1 confirms an ATP-competitive binding mode. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：5648 / 5652

页数：5

共 17 条

[1] READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES [J].

DESS, DB ;

MARTIN, JC .

JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (22) :4155-4156

[2]

DUBOIS JE, 1971, TETRAHEDRON LETT, P829

[3] Polo-like kinases and oncogenesis [J].

Eckerdt, F ;

Yuan, JP ;

Strebhardt, K .

ONCOGENE, 2005, 24 (02) :267-276

[4] Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1):: changes in the active-site conformation and interactions with ligands [J].

Elling, Robert A. ;

Fucini, Raymond V. ;

Romanowski, Michael J. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2008, 64 :909-918

[5] A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles [J].

Klapars, A ;

Antilla, JC ;

Huang, XH ;

Buchwald, SL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (31) :7727-7729

[6] The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1 [J].

Lenart, Peter ;

Petronczki, Mark ;

Steegmaier, Martin ;

Di Fiore, Barbara ;

Lipp, Jesse J. ;

Hoffmann, Matthias ;

Rettig, Wolfgang J. ;

Kraut, Norbert ;

Peters, Jan-Michael .

CURRENT BIOLOGY, 2007, 17 (04) :304-315

[7] Structure and function of Polo-like kinases [J].

Lowery, DM ;

Lim, D ;

Yaffe, MB .

ONCOGENE, 2005, 24 (02) :248-259

[8] PALLADIUM-CATALYZED CROSS-COUPLING REACTIONS OF ORGANOBORON COMPOUNDS [J].

MIYAURA, N ;

SUZUKI, A .

CHEMICAL REVIEWS, 1995, 95 (07) :2457-2483

[9] Probing cell-division phenotype space and Polo-like kinase function using small molecules [J].

Peters, Ulf ;

Cherian, Joseph ;

Kim, Jeffrey H. ;

Kwok, Benjamin H. ;

Kapoor, Tarun M. .

NATURE CHEMICAL BIOLOGY, 2006, 2 (11) :618-626

[10] PLK1 inhibitors: Setting the mitotic death trap [J].

Plyte, Simon ;

Musacchio, Andrea .

CURRENT BIOLOGY, 2007, 17 (08) :R280-R283

← 1 2 →